Anti-CCP antibody in patients with established rheumatoid arthritis: Does it predict adverse cardiovascular profile? - Wikidata - awgldk - TriplyDB

Anti-CCP antibody in patients with established rheumatoid arthritis: Does it predict adverse cardiovascular profile?

Anti-CCP antibody in patients with established rheumatoid arthritis: Does it predict adverse cardiovascular profile?

http://www.wikidata.org/entity/Q37163146

about

Left ventricular function in treatment-naive early rheumatoid arthritis.The count of tender rather than swollen joints correlates with aortic stiffness in patients with rheumatoid arthritis.Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis.Cardiovascular risk and the use of biologic agents in rheumatoid arthritis.Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study.Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX®: a registry study of RA with osteoporosis/fracture.Assessment of local carotid stiffness in seronegative and seropositive rheumatoid arthritis.Hearing impairment in patients with rheumatoid arthritis: association with anti-citrullinated protein antibodies.Tumor necrosis factor-α -308 polymorphism in North Indian rheumatoid arthritis patients and association with mRNA and serum TNF-α.Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks.Echocardiographic evaluation of diastolic dysfunction in rheumatoid arthritis - a case-control study.

P2860

Q33847043-B0C2221C-2BF1-4FBE-91EF-244881F54347 Q36788926-3AF512C9-6EAE-4C4A-AC0A-238E5852226D Q38230867-DABBE94E-1627-4656-A104-46610F85FCB7 Q38260198-469B6B3E-EFA6-4629-AF42-882BC481E2B8 Q40117130-2D54C38F-AEFB-41CE-A742-6C32BACF890F Q41617609-E7A6B4D1-DC2A-4A94-BC90-C15E3ACA7790 Q48139843-B42B63C6-50FF-44E5-9DE1-A3A66F2D2149 Q48548043-97C6581D-F3F3-4756-AAD0-D1EE6411CFEB Q50316556-C5A21DC0-6C79-4961-A1A6-F197E2C35C10 Q50518814-8F03CB4F-98D6-4BE0-96C7-C8511F3AA8EB Q51572553-39CC3306-0AB7-47CD-A763-C856610F6431 Q53656576-04361BC7-0D77-4A5D-9A8E-CB5AEEBA2448

P2860

Anti-CCP antibody in patients with established rheumatoid arthritis: Does it predict adverse cardiovascular profile?

http://www.wikidata.org/entity/Q37163146

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Anti-CCP antibody in patients ...... dverse cardiovascular profile?

@en

Anti-CCP antibody in patients ...... dverse cardiovascular profile?

@nl

type

label

Anti-CCP antibody in patients ...... dverse cardiovascular profile?

@en

Anti-CCP antibody in patients ...... dverse cardiovascular profile?

@nl

prefLabel

Anti-CCP antibody in patients ...... dverse cardiovascular profile?

@en

Anti-CCP antibody in patients ...... dverse cardiovascular profile?

@nl

P1433

Q37163146-8D474979-C3D2-496C-AC0A-3AB080DF7067

P1476

Q37163146-33301E43-C605-4A64-9D03-A08C6F0E20D1

P2093

Q37163146-0FA796B5-C882-4C03-B8A6-FA66503DD183

Q37163146-10076F01-C6BE-4FCE-902D-1C3DB7CC1571

Q37163146-5387BFEA-F799-423C-93D7-8EBBBB03D715

Q37163146-7EBF0137-3CF8-4274-BB80-BEF017EE5B83

Q37163146-DCDB7613-FD69-4027-8E14-CC4EC1C80F41

Q37163146-EBF579D7-F985-4FAC-848E-BECACC6A9FEB

P2860

Q37163146-0949A8A8-21C6-43C4-8251-EFDBF9A6704C

Q37163146-19776783-E985-46F2-982D-E536E2713E08

Q37163146-1D818FD1-86A6-447E-928B-B039FDA2143F

Q37163146-357F226A-62EF-4585-9ADD-646C7AF04179

Q37163146-3E34E0BC-EE62-434E-AA0D-E4AACC52311C

Q37163146-440B2C6D-A14F-49F9-AF60-C73DC3F4B3F0

Q37163146-7832E392-4982-4173-8877-67E73BCE5A72

Q37163146-7C880A34-1300-4349-A487-7978566E671E

Q37163146-97409042-E43A-43B5-8D43-99CDAA4A3BDB

Q37163146-A825B4F2-9C8A-4BDF-9F14-5235FA85D79C

P304

Q37163146-9645C932-53AE-4E78-A6C6-5C0BCEC3376F

P31

Q37163146-1FC9A3A6-BB66-444C-9E1E-847E62BCE412

P356

Q37163146-C66881FF-7BB3-446B-BDB7-4847D04D6582

P433

Q37163146-1AF4F1BA-2020-458F-9405-37B59B53FDA2

P478

Q37163146-50F80686-BBE1-40ED-8241-56FF017188D6

P577

Q37163146-C2AC5208-A13B-452F-B554-81A667FDB4A1

P5875

Q37163146-4F8B8FDE-317C-4A50-80A4-9D80D04B334F

P698

Q37163146-CB795510-2583-44FC-B398-4DCF71619B9E

P921

Q37163146-F66B65E2-F91E-4AE1-9D58-AFD0BB3F9F7E

P932

Q37163146-E5AA1180-75B2-4C2F-B471-FF57714286B7

P356

J.JCDR.2012.09.003

P1433

Journal of Cardiovascular Disease Research

P1476

Anti-CCP antibody in patients ...... dverse cardiovascular profile?

@en

P2093

Banerjee Arnab

http://www.w3.org/2001/XMLSchema#string

Ghosh Anirban

http://www.w3.org/2001/XMLSchema#string

Ghosh Biswadip

http://www.w3.org/2001/XMLSchema#string

Mandal Shyamash

http://www.w3.org/2001/XMLSchema#string

Palui Rajan

http://www.w3.org/2001/XMLSchema#string

Pande Arindam

http://www.w3.org/2001/XMLSchema#string

P2860

Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis

Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study

Are the anti-cyclic citrullinated peptide antibodies independent predictors of myocardial involvement in patients with active rheumatoid arthritis?

Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis.

Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis.

Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.

Accelerated atherosclerosis in rheumatoid arthritis.

Precocious atherosclerosis in rheumatoid arthritis: role of traditional and disease-related cardiovascular risk factors.

Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study.

P304

102-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCDR.2012.09.003

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256502064

http://www.w3.org/2001/XMLSchema#string

P698

24027365

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

3770122

http://www.w3.org/2001/XMLSchema#string